Dimensional Fund Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $390K | Sell |
335,966
-111,434
| -25% | -$129K | ﹤0.01% | 3033 |
|
|
2025
Q1 | $712K | Sell |
447,400
-57,606
| -11% | -$91.6K | ﹤0.01% | 2945 |
|
|
2024
Q4 | $1.53M | Sell |
505,006
-638
| -0.1% | -$1.93K | ﹤0.01% | 2846 |
|
|
2024
Q3 | $1.86M | Sell |
505,644
-121,019
| -19% | -$445K | ﹤0.01% | 2794 |
|
|
2024
Q2 | $2.56M | Sell |
626,663
-96,993
| -13% | -$397K | ﹤0.01% | 2701 |
|
|
2024
Q1 | $11.4M | Sell |
723,656
-377
| -0.1% | -$5.94K | ﹤0.01% | 2258 |
|
|
2023
Q4 | $11M | Buy |
724,033
+239,714
| +49% | +$3.63M | ﹤0.01% | 2286 |
|
|
2023
Q3 | $9.72M | Buy |
484,319
+110,415
| +30% | +$2.21M | ﹤0.01% | 2276 |
|
|
2023
Q2 | $10.5M | Buy |
373,904
+51,107
| +16% | +$1.44M | ﹤0.01% | 2234 |
|
|
2023
Q1 | $5.55M | Buy |
322,797
+189,766
| +143% | +$3.26M | ﹤0.01% | 2453 |
|
|
2022
Q4 | $2.68K | Buy |
133,031
+98,683
| +287% | +$1.99K | ﹤0.01% | 2648 |
|
|
2022
Q3 | $744K | Sell |
34,348
-37,362
| -52% | -$809K | ﹤0.01% | 2961 |
|
|
2022
Q2 | $2.01M | Sell |
71,710
-19,792
| -22% | -$556K | ﹤0.01% | 2736 |
|
|
2022
Q1 | $4.22M | Buy |
+91,502
| New | +$4.22M | ﹤0.01% | 2585 |
|